Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

MajesTEC-3 - Daratumumab 1800 / Teclistamab 1.5, Multiple Myeloma, cycle 2

Protocol-ID: 3086 V1.1 (Mini), MajesTEC-3 - DRTM1800/TECL1.5, MM, C2

Indication(s)

  • Multiple Myeloma; ICD-10 C90.-, C90.0-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician.

Valid since: 06.10.2026